What is the immediate management of Post Partum Hemorrhage (PPH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Management of Postpartum Hemorrhage

Administer tranexamic acid 1 g IV over 10 minutes within 3 hours of birth alongside oxytocin 5-10 IU (IV or IM), initiate uterine massage and bimanual compression, and begin fluid resuscitation with physiologic electrolyte solutions. 1

Time-Critical Pharmacological Interventions

Tranexamic Acid (TXA) - First Priority

  • Give TXA 1 g IV over 10 minutes immediately upon diagnosis of PPH, regardless of the cause (uterine atony, trauma, or retained tissue). 2, 1
  • TXA must be administered within 3 hours of birth—effectiveness decreases by approximately 10% for every 15 minutes of delay, and administration beyond 3 hours may be harmful. 2, 1, 3
  • A second dose of TXA 1 g IV can be given if bleeding continues after 30 minutes or restarts within 24 hours. 2, 1, 3
  • The number needed to treat is 276 to prevent one bleeding-related death. 3

Oxytocin - Simultaneous Administration

  • Administer oxytocin 5-10 IU slow IV or IM immediately; the IV route is more effective than IM for PPH prevention. 2, 4
  • For ongoing hemorrhage, escalate to 10-40 units of oxytocin in 1,000 mL of physiologic electrolyte solution, infused at a rate necessary to control uterine atony. 4
  • Higher oxytocin doses (up to 80 IU) are associated with a 47% reduction in PPH compared to lower doses (10 IU). 2

Immediate Physical Maneuvers

  • Initiate uterine massage and bimanual compression immediately. 1
  • Bimanual compression involves placing one fist in the anterior vaginal fornix against the anterior uterine wall while the other hand compresses the posterior uterus through the abdomen. 5
  • External aortic compression can be used for temporary stabilization while arranging definitive care. 2

Fluid Resuscitation and Blood Product Management

  • Begin IV fluid resuscitation with physiologic electrolyte solutions immediately. 2, 1
  • Initiate massive transfusion protocol if blood loss exceeds 1,500 mL. 1
  • Transfuse packed RBCs, fresh frozen plasma, and platelets in fixed ratio—do not delay transfusion waiting for laboratory results in severe bleeding. 1
  • Target hemoglobin >8 g/dL and fibrinogen ≥2 g/L during active hemorrhage. 1

Second-Line Pharmacological Agents

When Oxytocin Fails

  • Carboprost (Hemabate) 250 mcg IM deep injection is indicated for PPH due to uterine atony unresponsive to oxytocin. 6
  • The majority of successful cases (73%) respond to a single injection; additional doses can be given at 15-90 minute intervals. 6
  • Total dose should not exceed 2 mg (8 doses). 6

Contraindications and Cautions

  • Methylergonovine 0.2 mg IM is contraindicated in hypertensive patients (>10% risk of severe vasoconstriction and hypertensive crisis). 2, 1, 3
  • Methylergonovine should also be avoided in women with asthma due to bronchospasm risk. 1
  • Prostaglandin F analogues are contraindicated when an increase in pulmonary artery pressure is undesirable. 2

Mechanical Interventions - Sequential Escalation

Intrauterine Balloon Tamponade

  • Implement intrauterine balloon tamponade before proceeding to surgery or interventional radiology, with a success rate of 90% when properly placed. 2, 1
  • Success rates range from 79.4% to 88.2% in uterine atony cases. 2

Uterine Packing

  • Pelvic pressure packing is effective for acute uncontrolled hemorrhage stabilization and can remain for 24 hours. 1

Non-Pneumatic Antishock Garment

  • Can be used for temporary stabilization while arranging definitive care. 2, 1

Identifying the Cause - The "Four T's"

  • Tone (uterine atony): Most common cause (>75% of cases); treat with uterotonics and uterine massage. 1, 5
  • Trauma (lacerations, rupture): Requires careful visual inspection and surgical repair; CT with IV contrast is useful in hemodynamically stable patients to localize bleeding. 1
  • Tissue (retained placenta/products): Manual removal should not be performed routinely except in severe, uncontrollable PPH; ultrasound can diagnose retained products. 7, 1, 3
  • Thrombin (coagulopathy): Requires correction with blood products and factor replacement. 5

Surgical Interventions - When Conservative Measures Fail

  • Uterine compression sutures (B-Lynch or similar brace sutures) can control bleeding when medical and balloon tamponade measures fail. 1
  • Arterial embolization is particularly useful when no single bleeding source is identified, but requires hemodynamic stability for transfer. 1
  • Systematic pelvic devascularization (uterine artery ligation, internal iliac artery ligation) may be attempted before hysterectomy. 8
  • Subtotal or total abdominal hysterectomy is the definitive surgical intervention when all other measures fail. 8

Essential Supportive Measures

  • Maintain normothermia: Warm all infusion solutions and blood products; use active skin warming, as clotting factors function poorly at lower temperatures. 1
  • Administer supplemental oxygen in severe PPH. 1
  • Re-dose prophylactic antibiotics if blood loss exceeds 1,500 mL. 1
  • Continue hemodynamic monitoring for at least 24 hours post-delivery due to significant fluid shifts that may precipitate heart failure in women with structural heart disease. 2, 1

Critical Pitfalls to Avoid

  • Do not delay TXA administration—every 15 minutes of delay reduces effectiveness by 10%, and administration beyond 3 hours may cause harm. 2, 1, 3
  • Do not perform manual removal of placenta before 30 minutes have elapsed unless there is severe, uncontrollable hemorrhage, as this increases infection and hemorrhage risk. 7, 3
  • Do not use methylergonovine in hypertensive patients or those with asthma. 2, 1, 3
  • Do not delay blood transfusion waiting for laboratory results in severe bleeding. 1

Special Populations

Anticoagulated Patients

  • Active management with uterotonics (oxytocin) is critical, as the primary mechanism of placental bed hemostasis is myometrial contraction, not coagulation. 2
  • If emergent delivery is required on therapeutic anticoagulation, consider protamine (partially reverses LMWH). 1
  • Caesarean delivery is preferred to reduce fetal intracranial hemorrhage risk. 1

Post-Hemorrhage Monitoring

  • Monitor for complications: renal failure, liver failure, infection, Sheehan syndrome. 1
  • Consider thromboprophylaxis after bleeding is controlled, especially with additional VTE risk factors. 1
  • Early ambulation with elastic support stockings can reduce thromboembolism risk. 1

References

Guideline

Management of Postpartum Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Postpartum Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Third Stage of Labour

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Postpartum Hemorrhage: Prevention and Treatment.

American family physician, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Surgical aspects of postpartum haemorrhage.

Best practice & research. Clinical obstetrics & gynaecology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.